The PATHway Study: Primary Care Based Depression Prevention in Adolescents (PATHway)

January 6, 2026 updated by: Benjamin Van Voorhees, MD, MPH, University of Illinois at Chicago

Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.

Study Overview

Detailed Description

With more than 13% of adolescents diagnosed with depressive disorders each year, prevention of depressive disorders has become a key priority for the National Institute of Mental Health (NIMH). Unfortunately, the investigators have no widely available interventions to reduce morbidity and mortality (e.g. public health impact). To address this need, the investigators developed a multi-health system "collaboratory" to develop and evaluate the primary care based technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT) (14 adolescent, 5 parent modules). Using this health-system collaboratory model, the full CATCH-IT program (all modules), demonstrated evidence of efficacy in prevention of depressive episodes in phase-three clinical trials in the United States and China. However, like many "package" interventions, CATCH-IT became larger and more complex across efficacy trials. Thus, adolescents were less willing to complete all 14 modules, suggesting adolescent dose "tolerability" issues (e.g., satisfaction, acceptability and resource use, "time as cost"). Similarly, primary care practices have "scalability" challenges (acceptability, feasibility, resource use, cost), resulting in declining REACH (percent of at-risk youth who complete intervention). To prepare for implementation studies and dissemination, the investigators need to address adolescent tolerability and practice/health system scalability, while preserving efficacy. Multiphase Optimization Strategy (MOST) uses a systematic analytic approach and a factorial randomized clinical trial design to address efficacy, tolerability, and scalability, simultaneously. The investigators will use a MOST approach to optimize CATCH-IT for the prevention of depression (indicated prevention, i.e., elevated symptoms of depression) in practices and health systems representative of US geography and population. The theoretically grounded components of CATCH-IT selected for study and optimization include: behavioral activation, cognitive-behavioral therapy, interpersonal psychotherapy, and parent program. The investigators will use a 4-factor (2x2x2x2) fully crossed factorial design with N=16 cells (25 per cell, 15% dropout) to evaluate the contribution of each component. The investigators propose to randomize N=400 adolescents from multiple sites: Advocate-Aurora Health Care (n=200); Lurie Children's Hospital (n=70); NorthShore University HealthSystem (n=70); University of Chicago Comer Hospital (n=25); University of Texas (n=20); University of Illinois College of Medicine Peoria (n=15). The at-risk youth will be high school students 13 through 18 years old, not currently experiencing a mood disorder, but with subsyndromal symptoms of depression (moderate to high risk). Using the efficient factorial design, the investigators can assess the contribution to prevention efficacy of each component. Thus, the MOST study design will enable us to eliminate non-contributing components while preserving efficacy and to optimize CATCH-IT by strengthening tolerability and scalability by reducing "resource use." By reducing resource use, the investigators anticipate satisfaction and acceptability will also increase, preparing the way for an implementation trial and eventual US Preventive Services Task Force endorsement to support dissemination. Thus, the primary question is whether one component, or perhaps two, can demonstrate an equivalent effect to combinations of other components in terms of efficacy, whilst also demonstrating superior adolescent/family tolerability scalability over a 12-month follow-up.

Study Type

Interventional

Enrollment (Actual)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Ann & Robert H. Lurie Children's Hospital of Chicago
      • Chicago, Illinois, United States, 60637
        • University of Chicago Comer Children's Hospital
      • Chicago, Illinois, United States, 60612
        • UI Health
      • Glenview, Illinois, United States, 60026
        • NorthShore University Healthsystem
      • Park Ridge, Illinois, United States, 60068
        • Advocate Aurora Health
    • Texas
      • Dallas, Texas, United States, 75390
        • UT Southwestern Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adolescents ages 13 through 18 years, and
  • Adolescents must be experiencing an elevated level of depressive symptoms (PHQ-9 = 5-18), and
  • Adolescents will be included if they have had past depressive episode/s, but not if they are in a current depressive episode.

Exclusion Criteria:

  1. Outside age range:

    1. 12 or younger
    2. 19 or older
  2. Adolescent is a non-English speaker/reader
  3. On the PHQ-9 screening, depression symptom level is:

    1. PHQ-9 = 4 or lower
    2. PHQ-9 =19 or higher
  4. As assessed by the MINI Kid, a current depressive episode
  5. As assessed by the MINI Kid, adolescent meets DSM-5 criteria for a psychotic or bipolar disorder.
  6. Currently using medication therapy for depression, anxiety, or other internalizing disorders.
  7. Currently engaged in individual treatment for a mood disorder (assessed by BCC during phone screen)
  8. Currently engaged in a cognitive-behavioral group or therapy (assessed by BCC during phone screen)
  9. Any past psychiatric hospitalizations
  10. Any past suicide attempt or incident of self-harm with moderate or greater lethality
  11. Extreme, current drug/alcohol abuse (determined by clinician follow up following a score of 3 or greater on the CRAFFT)
  12. Current suicidal thoughts

    1. Eligibility will be determined on a case-by-case basis during the baseline PhQ-9 and MINI Kid assessment process and after a consultation with a licensed mental health clinician has taken place. If adolescent report suicidal ideation on the baseline PhQ-9, and found ineligible, the MINI Kid assessment may not be required.
    2. Adolescents with current (within the past 6 months), active suicidal feelings will be excluded.
    3. Adolescents with passive thoughts of death or suicide but report to the mental health clinician that they would never act on these thoughts may be admitted, depending on the severity of the risk.
    4. Adolescents with past (greater than 6 months ago) ideation who are determined to be low risk will be admitted into the study if there has never been an attempt of moderate or greater lethality.
  13. Significant reading impairment (a minimum sixth-grade reading level based on parental report) and/or significant intellectual or developmental disabilities
  14. Not willing to comply with the study protocol
  15. Did not complete phone assessment with MINI Kid by BCC
  16. Not affiliated with any of the sites listed in Appendix A.
  17. Parent/guardian does not speak English or Spanish
  18. Parent/guardian has a cognitive or intellectual impairment
  19. Participant Declined/Changed Mind/Uninterested in participating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 1. No adolescent modules + no parent modules
No adolescent nor parent modules will be offered to the participant.
Experimental: 2. Adolescent behavioral activation modules only
Adolescent behavioral activation modules only
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 3. Adolescent cognitive-behavioral therapy modules only
Adolescent cognitive-behavioral therapy modules only
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 4. Adolescent interpersonal therapy modules only
Adolescent interpersonal therapy modules only
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 5. Adolescent behavioral activation modules + cognitive-behavioral therapy modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 6. Adolescent behavioral activation modules + interpersonal therapy modules
Adolescent behavioral activation modules Adolescent interpersonal therapy modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 7. Adolescent cognitive-behavioral therapy modules + interpersonal therapy modules
Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 8. Full Adolescent program only
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 9. Parent program modules only
Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 10. Adolescent behavioral activation modules + parent program modules
Adolescent behavioral activation modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 11. Adolescent cognitive-behavioral therapy modules + parent program modules
Adolescent cognitive-behavioral therapy modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 12. Adolescent interpersonal therapy modules + parent program modules
Adolescent interpersonal therapy modules Parent Program
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 13. Adolescent behavioral activation + cognitive-behavioral therapy + parent program modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 14. Adolescent behavioral activation + interpersonal therapy + parent program modules
Adolescent behavioral activation modules Adolescent interpersonal therapy modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Experimental: 15. Adolescent cognitive-behavioral therapy + interpersonal therapy + parent program modules
Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT
Active Comparator: 16. All adolescent + parent program modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
  • CATCH-IT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time
Time Frame: Baseline through 12 months
Time will be measured to nearest minute for all intervention related activities including initial screening, engagement phone calls, use of CATCH-IT. Time will be measured from adolescent, family, practice, community center, healthcare organization, health system perspective. For time that cannot be directly measured by study staff, the investigators will sample direct observation or questionnaires to capture time required for health system related activities such as screening and engagement.
Baseline through 12 months
Cultural acceptability adolescent and family
Time Frame: Baseline through 12 months
Cultural acceptability for each stakeholder using appropriate, validated instruments. Adolescent and family: Usefulness, Satisfaction, and Ease Questionnaire (USE, 30 items, self-report, 7-point Likert scale, 30-210 score range, higher score indicates more acceptable). An example statement is: "I would recommend this to a friend."
Baseline through 12 months
Cost
Time Frame: Baseline through 12 months
Costs will be measured for all stakeholders. For practice, community center, healthcare organizations, health systems, cost will be measured to nearest dollar by converting time measures into employment related costs based on mean wages and benefits for staff at that occupational level. Adolescent and family costs will be measured by converting time into mean hourly wages and benefits for adolescent and family members involved in the project (based on mean wage for age and occupation).
Baseline through 12 months
Depressive Symptoms
Time Frame: Baseline through 12 months
Patient Health Questionnaire-Adolescent (PHQ-A, 9 items plus 4 follow-up items, self-report, 3-point Likert scale, 0-27 score range, higher score indicates more depression symptoms/severity).
Baseline through 12 months
Depressive and mental disorder episodes
Time Frame: Baseline through 12 months
Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid, self-report). This is a structured psychiatric interview administered by a trained staff member which uses stem questions and follow-ups to determine the presence of symptoms and date of onset. The staff member then determines if and when the symptoms developed an episode is present. Measure is either episode present or not and date of onset.
Baseline through 12 months
Stress symptoms
Time Frame: Baseline through 12 months
Center for Epidemiological Studies-Depression Scale (CES-D, 20 items, self-report, measured in frequency, 0,"not at all" to 3, "nearly every day in last week, 0-60 score range, higher score indicates more depressed).
Baseline through 12 months
Resiliency
Time Frame: Baseline through 12 months
Resiliency will be measured across multiple domains. To assess resiliency in terms of coping skills, the Connor-Davidson Resilience Scale (CD-RISC, 10 items, self-report, 4 levels of response, 0-40 score range, higher score indicates better coping skills).
Baseline through 12 months
Function
Time Frame: Baseline through 12 months
Social Adjustment Scale Self-Report (SAS-SR, 23-items, self-report, 5-point Likert scale, 23-115 score range, higher score indicates higher levels of social adjustment) administered to adolescents only.
Baseline through 12 months
Relationships (Life Events)
Time Frame: Baseline through 12 months
University of California at Los Angeles (UCLA) Life Events Scale (19-items, self-report) administered to adolescents only.
Baseline through 12 months
Socio-cultural Relevance
Time Frame: Baseline through 12 months
The Socio-Cultural Relevance Scale (10-item and 14-item versions, self-report, 5-point Likert scale, 10-40 or 14-56 score ranges, higher score indicates greater socio-cultural relevance) will assess perceived change and satisfaction with the intervention, component of cultural acceptability to adolescent)
Baseline through 12 months
Acceptability of Intervention
Time Frame: Start to end of recruitment, 32 months
Acceptability of Intervention Measure (AIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater acceptability of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
Start to end of recruitment, 32 months
Feasibility of Intervention
Time Frame: Start to end of recruitment, 32 months
Feasibility of Intervention Measure (FIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater feasibility of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
Start to end of recruitment, 32 months
Intervention Appropriateness
Time Frame: Start to end of recruitment, 32 months
Intervention Appropriateness Measure (IAM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater appropriateness of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
Start to end of recruitment, 32 months
Externalizing Behavior Symptoms
Time Frame: Baseline through 12 months
Disruptive Behavior Disorders Rating Scale-Adolescent (DBD-A, 41-items, self-report, 4-point Likert scale, 0-123 score range, higher score indicates greater externalizing symptoms).
Baseline through 12 months
Anxiety Symptoms
Time Frame: Baseline through 12 months
Screen for Child Anxiety Related Disorders (SCARED, 41-items, self-report, 3-point Likert scale, 0-82 score range, higher score indicates greater anxiety symptoms).
Baseline through 12 months
Substance Abuse Symptoms
Time Frame: Baseline through 12 months
Car, Relax, Alone, Forget, Friends, Trouble substance use assessment (CRAFFT, 6 items, self-report, 2-point scale, 0-6 score range, higher score indicates greater substance abuse symptoms).
Baseline through 12 months
Post Traumatic Stress Disorder Symptoms
Time Frame: Baseline through 12 months
Child Post Traumatic Symptoms Disorder Scale (24-items, self-report, 4-point Likert scale, 0-72 score range, higher score indicates greater PTSD symptom levels).
Baseline through 12 months
Rumination
Time Frame: Baseline through 12 months
Tendency towards rumination will be assessed by the Children's Response Style Scale (CRSS, 10-items, self-report, 5-point Likert scale, 0-50 score range, higher score indicates greater rumination (more repeated negative thinking, less resilient, component of resiliency).
Baseline through 12 months
Dysfunctional Attitudes
Time Frame: Baseline through 12 months
The Dysfunctional Attitude Scale (DAS, 9-item, self-report, 7-point Likert scale, 9-63 score range, higher score indicates more dysfunctional attitude, less resiliency, component of resiliency).
Baseline through 12 months
Family Relationships
Time Frame: Baseline through 12 months
Child Report of Parental Behavior Inventory (CRPBI, 30-item, self-report, 3-point Likert scale, 0-60 score range, higher scores indicate more positive parent child relationship).
Baseline through 12 months
Cognitive Style
Time Frame: Baseline through 12 months
The Children's Cognitive Style Questionnaire (CCSQ, 6-items, self-report, 5-point Likert scale, 0-150 range, higher score indicates greater negativity of cognitive style).
Baseline through 12 months
Self-efficacy
Time Frame: Baseline through 12 months
The Trans-Theoretical Model Scale (TTMS, 10-item, self-report, 4-point Likert scale, 0-24 range, higher score indicates higher self-efficacy and intention to reduce depressive symptoms).
Baseline through 12 months
Social Adjustment
Time Frame: Baseline through 12 months
The Social Adjustment Scale-Adolescent version (SAS-SR, 23-item, self-report, 5-point Likert scale, 0-115 range, higher score indicates higher level of social dysfunction).
Baseline through 12 months
Systolic and diastolic blood pressure
Time Frame: At baseline
Measured in millimeters of mercury.
At baseline
Height
Time Frame: At baseline
Measure by standard medical office practice measure, without shoes, in centimeters.
At baseline
Weight
Time Frame: At baseline
Measured in kilograms by standard medical office scale, fully clothed participant.
At baseline
Body Mass Index
Time Frame: At baseline
Calculated by measuring height (centimeters) and weight (kilogram) to calculate kg/meters squared (BMI, Body Mass Index).
At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moderation of COVID-19-related behaviors and consequences
Time Frame: Baseline through 12 months
The investigators will examine COVID-19-related behaviors and consequences (e.g. social distancing, sheltering-in-place, family illness and death) that that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater behaviors and consequences).
Baseline through 12 months
Moderation of COVID-19-related social determinants of health
Time Frame: Baseline through 12 months
The investigators will examine COVID-19-related social determinants of health (e.g. food insecurity, internet access, unemployment) that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater number of social determinants).
Baseline through 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benjamin W Van Voorhees, MD, MPH, UIC, College of Medicine
  • Principal Investigator: Tracy RG Gladstone, PhD, Wellesley College
  • Study Director: Calvin Rusiewski, MBBS, UIC, College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

October 31, 2024

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

January 10, 2022

First Submitted That Met QC Criteria

January 10, 2022

First Posted (Actual)

January 24, 2022

Study Record Updates

Last Update Posted (Estimated)

January 8, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHAIRb 20080601
  • 1R01MH124723-01 (U.S. NIH Grant/Contract)
  • 3R01MH124723-04S1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Subscribe